Treatment of experimental glioma by administration of adenoviral vectors expressing Fas ligand.

作者: Benjamin B. Ambar , Karl Frei , Ursula Malipiero , Adrian E. Morelli , Maria G. Castro

DOI: 10.1089/10430349950017644

关键词: Cancer researchCytotoxic T cellCytokineGenetic enhancementFas ligandGliomaCell cultureApoptosisAdenoviridaeBiologyVirology

摘要: Fas ligand (FasL) is a cytokine, produced by activated T cells and NK cells, that triggers apoptosis of Fas-positive target including human glioma cells. As shown here, in vitro infection rat F98 LN18 cell lines with recombinant adenovirus (rAd) expressing FasL cDNA under control the cytomegalovirus promoter (rAd-CMV-FasL) induced striking cytotoxicity but not Fas-negative subline F98/ZH. The extent FasL-mediated cytotoxic effects outranged expectations based on expression beta-galactosidase (beta-Gal) infected virus lacZ gene (rAd-CMV-lacZ). detection bioactivity supernatants provides evidence bystander mechanism involving action uninfected In tumor-bearing rats, rAd-CMV-FasL increased mean survival time 50% compared rAd-CMV-lacZ or untreated controls. These ...

参考文章(26)
M. Wrann, S. Bodmer, R. de Martin, C. Siepl, R. Hofer-Warbinek, K. Frei, E. Hofer, A. Fontana, T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-beta. The EMBO Journal. ,vol. 6, pp. 1633- 1636 ,(1987) , 10.1002/J.1460-2075.1987.TB02411.X
Henning Walczak, Robert E. Miller, Kiley Ariail, Brian Gliniak, Thomas S. Griffith, Marek Kubin, Wilson Chin, Jon Jones, Anne Woodward, Tiep Le, Craig Smith, Pam Smolak, Raymond G. Goodwin, Charles T. Rauch, JoAnn C.L. Schuh, David H. Lynch, Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo Nature Medicine. ,vol. 5, pp. 157- 163 ,(1999) , 10.1038/5517
M. Tanaka, T. Suda, T. Takahashi, S. Nagata, Expression of the functional soluble form of human fas ligand in activated lymphocytes. The EMBO Journal. ,vol. 14, pp. 1129- 1135 ,(1995) , 10.1002/J.1460-2075.1995.TB07096.X
Nancy R. Clendenon, Wanda A. Gordon, Rolf F. Barth, Jone-Jiun Tzeng, Adoptive Immunotherapy of a Rat Glioma Using Lymphokine-activated Killer Cells and Interleukin 2 Cancer Research. ,vol. 50, pp. 4338- 4343 ,(1990)
A Fontana, S Bodmer, E Hofer, R M Zinkernagel, M H Schreier, M A Palladino, K Frei, Transforming growth factor-beta inhibits the generation of cytotoxic T cells in virus-infected mice. Journal of Immunology. ,vol. 143, pp. 3230- 3234 ,(1989)
Pascal Schneider, Nils Holler, Jean-Luc Bodmer, Michael Hahne, Karl Frei, Adriano Fontana, Jürg Tschopp, Conversion of Membrane-bound Fas(CD95) Ligand to Its Soluble Form Is Associated with Downregulation of Its Proapoptotic Activity and Loss of Liver Toxicity Journal of Experimental Medicine. ,vol. 187, pp. 1205- 1213 ,(1998) , 10.1084/JEM.187.8.1205
B. Trauth, C Klas, A. Peters, S Matzku, P Moller, W Falk, K. Debatin, P. Krammer, Monoclonal antibody-mediated tumor regression by induction of apoptosis Science. ,vol. 245, pp. 301- 305 ,(1989) , 10.1126/SCIENCE.2787530
Shigekazu Nagata, Apoptosis by death factor. Cell. ,vol. 88, pp. 355- 365 ,(1997) , 10.1016/S0092-8674(00)81874-7
P Saas, P R Walker, M Hahne, A L Quiquerez, V Schnuriger, G Perrin, L French, E G Van Meir, N de Tribolet, J Tschopp, P Y Dietrich, Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain? Journal of Clinical Investigation. ,vol. 99, pp. 1173- 1178 ,(1997) , 10.1172/JCI119273